STOCK TITAN

Ginkgo Bioworks Holdings Inc Stock Price, News & Analysis

DNA NYSE

Welcome to our dedicated page for Ginkgo Bioworks Holdings news (Ticker: DNA), a resource for investors and traders seeking the latest updates and insights on Ginkgo Bioworks Holdings stock.

Ginkgo Bioworks Holdings Inc (NYSE: DNA) operates at the forefront of synthetic biology, combining cell programming expertise with biosecurity solutions for industries ranging from pharmaceuticals to agriculture. This news hub provides investors and industry professionals with essential updates on the company's strategic initiatives and technological advancements.

Access real-time announcements including earnings reports, R&D breakthroughs, and strategic partnerships that demonstrate Ginkgo's leadership in biological engineering. The platform serves as a comprehensive resource for tracking developments in their core Cell Engineering services and Biosecurity programs.

Discover updates on Ginkgo's AI-driven innovations, government contracts, and cross-industry collaborations that shape the future of synthetic biology. Content is curated to help stakeholders understand how biological engineering advancements translate to commercial opportunities.

Bookmark this page for streamlined access to verified financial disclosures, operational milestones, and analysis of emerging trends in cell programming technology. Regular updates ensure you stay informed about developments impacting DNA's market position and sector leadership.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.91%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.85%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.48%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
partnership
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.87%
Tags
partnership
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.1%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.09%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.88%
Tags
none
Rhea-AI Summary

Visolis has partnered with Ginkgo Bioworks (NYSE: DNA) to enhance the production of bio-based isoprene and sustainable aviation fuels (SAF). This collaboration aims to leverage Ginkgo's strain engineering capabilities to improve microbial efficiency for producing a key feedstock ingredient. Bio-based isoprene is crucial for decarbonizing rubber tire manufacturing, while SAF offers a lower carbon intensity alternative in aviation. Visolis employs a novel two-step process for isoprene production, enhancing stability and reliability. The partnership is expected to optimize production processes, with both companies expressing pride in contributing to carbon-negative solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.05%
Tags
partnership

FAQ

What is the current stock price of Ginkgo Bioworks Holdings (DNA)?

The current stock price of Ginkgo Bioworks Holdings (DNA) is $6.85 as of May 22, 2025.

What is the market cap of Ginkgo Bioworks Holdings (DNA)?

The market cap of Ginkgo Bioworks Holdings (DNA) is approximately 458.3M.
Ginkgo Bioworks Holdings Inc

NYSE:DNA

DNA Rankings

DNA Stock Data

458.30M
54.82M
6.6%
79.85%
15.62%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
BOSTON